NYSE:UPC

Universe Pharmaceuticals (UPC) Stock Price, News & Analysis

$2.18
+0.03 (+1.40%)
(As of 05/6/2024 ET)
Today's Range
$2.17
$2.27
50-Day Range
$1.46
$2.75
52-Week Range
$0.75
$5.88
Volume
5,518 shs
Average Volume
75,158 shs
Market Capitalization
$7.89 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
UPC stock logo

About Universe Pharmaceuticals Stock (NYSE:UPC)

Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. The company also distributes and sells third-party products, including biomedical drugs, medical instruments, traditional Chinese medicine pieces, and dietary supplements. Its customers include pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was founded in 1998 and is based in Ji'An, China. Universe Pharmaceuticals INC operates as a subsidiary of Sununion Holding Group Limited.

UPC Stock Price History

UPC Stock News Headlines

Do NOT read if you believe in “woke” politics
I have to warn you, however: This CEO of a publicly traded company is not afraid to mince words. Many on Wall Street have refused to work with him.
Universe Pharmaceuticals Inc (UPC)
Universe Pharmaceuticals Inc UPC
Do NOT read if you believe in “woke” politics
I have to warn you, however: This CEO of a publicly traded company is not afraid to mince words. Many on Wall Street have refused to work with him.
Marvel Cinematic Universe
Universe of Art
UPC Universe Pharmaceuticals INC
UPC declares insolvency, appointed to receivership
See More Headlines
Receive UPC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Universe Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
5/07/2024
Fiscal Year End
9/30/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Fax
N/A
Employees
225
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$32.31 million
Book Value
$10.91 per share

Miscellaneous

Free Float
1,545,000
Market Cap
$7.90 million
Optionable
Not Optionable
Beta
1.66
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

  • Mr. Gang Lai (Age 56)
    CEO & Chairman
  • Ms. Lin Yang (Age 48)
    CFO & Director
  • Mr. Baochang Liu (Age 44)
    Chief Operating Officer

UPC Stock Analysis - Frequently Asked Questions

How have UPC shares performed in 2024?

Universe Pharmaceuticals' stock was trading at $2.01 at the beginning of the year. Since then, UPC stock has increased by 8.5% and is now trading at $2.18.
View the best growth stocks for 2024 here
.

When did Universe Pharmaceuticals' stock split?

Shares of Universe Pharmaceuticals reverse split on Friday, July 28th 2023. The 1-6 reverse split was announced on Friday, July 28th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Friday, July 28th 2023. An investor that had 100 shares of stock prior to the reverse split would have 17 shares after the split.

When did Universe Pharmaceuticals IPO?

Universe Pharmaceuticals (UPC) raised $30 million in an IPO on Tuesday, March 23rd 2021. The company issued 5,000,000 shares at $5.00-$7.00 per share. Univest Securities, LLC acted as the underwriter for the IPO.

How do I buy shares of Universe Pharmaceuticals?

Shares of UPC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:UPC) was last updated on 5/7/2024 by MarketBeat.com Staff

From Our Partners